SENSOMEDICAL

Executive Summary

Sensomedical is an Israeli med‑tech company providing a one‑stop‑shop service for the rapid development, prototyping, and commercialization of neuro‑technology products. Leveraging proprietary platforms—BIOPOT3, BIOCHEM, and BIOSTIM—the company designs wearable and implantable electrodes, EEG caps, and active neuro‑stimulators, guiding clients through FDA/CE approval and scale‑up. Its therapeutic focus spans neurodegenerative, psychiatric, and metabolic brain disorders. With over a decade of experience and a team of 50–200 employees, Sensomedical positions itself as a critical enabler for innovators in the neuro‑technology space. The platform model allows it to support multiple client programs simultaneously, reducing time‑to‑market and development costs for novel neuromodulation and sensing devices. By offering integrated services from concept to commercialization, Sensomedical captures value across the entire product lifecycle and mitigates the risk of relying on a single therapeutic asset. The global neuro‑technology market is expected to grow significantly, driven by rising prevalence of neurological disorders and increasing demand for non‑invasive diagnostic and therapeutic tools. Sensomedical’s established infrastructure and regulatory expertise give it a competitive edge in serving both startups and established medical device companies. As the company continues to onboard new clients and expand its platform capabilities, it is well‑positioned to benefit from the outsourcing trend in med‑tech development. However, the lack of publicly disclosed financials or specific pipeline projects introduces uncertainty regarding near‑term revenue visibility and valuation.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for a client device using BIOPOT3 platform70% success
• Q2 2027Major partnership with a top‑20 pharmaceutical company for neuro‑stimulation development50% success
• Q1 2027Launch of next‑generation BIOSTIM platform with enhanced wireless capabilities80% success